These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24644242)

  • 1. GTP cyclohydrolase I prevents diabetic-impaired endothelial progenitor cells and wound healing by suppressing oxidative stress/thrombospondin-1.
    Tie L; Chen LY; Chen DD; Xie HH; Channon KM; Chen AF
    Am J Physiol Endocrinol Metab; 2014 May; 306(10):E1120-31. PubMed ID: 24644242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GTP cyclohydrolase I/BH4 pathway protects EPCs via suppressing oxidative stress and thrombospondin-1 in salt-sensitive hypertension.
    Xie HH; Zhou S; Chen DD; Channon KM; Su DF; Chen AF
    Hypertension; 2010 Dec; 56(6):1137-44. PubMed ID: 21059996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-specific GTP cyclohydrolase I overexpression accelerates refractory wound healing by suppressing oxidative stress in diabetes.
    Tie L; Li XJ; Wang X; Channon KM; Chen AF
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1423-9. PubMed ID: 19336662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression.
    Alp NJ; Mussa S; Khoo J; Cai S; Guzik T; Jefferson A; Goh N; Rockett KA; Channon KM
    J Clin Invest; 2003 Sep; 112(5):725-35. PubMed ID: 12952921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium-specific GTP cyclohydrolase I overexpression attenuates blood pressure progression in salt-sensitive low-renin hypertension.
    Du YH; Guan YY; Alp NJ; Channon KM; Chen AF
    Circulation; 2008 Feb; 117(8):1045-54. PubMed ID: 18268143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shear stress-mediated upregulation of GTP cyclohydrolase/tetrahydrobiopterin pathway ameliorates hypertension-related decline in reendothelialization capacity of endothelial progenitor cells.
    Bai YP; Xiao S; Tang YB; Tan Z; Tang H; Ren Z; Zeng H; Yang Z
    J Hypertens; 2017 Apr; 35(4):784-797. PubMed ID: 28033126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression.
    Bendall JK; Alp NJ; Warrick N; Cai S; Adlam D; Rockett K; Yokoyama M; Kawashima S; Channon KM
    Circ Res; 2005 Oct; 97(9):864-71. PubMed ID: 16179591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium-targeted transgenic GTP-cyclohydrolase I overexpression inhibits neointima formation in mouse carotid artery.
    Liao SJ; Lin L; Zeng JS; Huang RX; Channon KM; Chen AF
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1260-6. PubMed ID: 17973864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression.
    Crabtree MJ; Tatham AL; Al-Wakeel Y; Warrick N; Hale AB; Cai S; Channon KM; Alp NJ
    J Biol Chem; 2009 Jan; 284(2):1136-44. PubMed ID: 19011239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice.
    Alp NJ; McAteer MA; Khoo J; Choudhury RP; Channon KM
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):445-50. PubMed ID: 14707037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diazoxide accelerates wound healing by improving EPC function.
    Li ZP; Xin RJ; Yang H; Jiang GJ; Deng YP; Li DJ; Shen FM
    Front Biosci (Landmark Ed); 2016 Jun; 21(5):1039-51. PubMed ID: 27100489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of endothelial guanosine triphosphate cyclohydrolase I ameliorates diabetic nephropathy.
    Kidokoro K; Satoh M; Channon KM; Yada T; Sasaki T; Kashihara N
    J Am Soc Nephrol; 2013 Jun; 24(7):1139-50. PubMed ID: 23620395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between nitric oxide-mediated endothelial function, eNOS coupling and blood pressure revealed by eNOS-GTP cyclohydrolase 1 double transgenic mice.
    Adlam D; Bendall JK; De Bono JP; Alp NJ; Khoo J; Nicoli T; Yokoyama M; Kawashima S; Channon KM
    Exp Physiol; 2007 Jan; 92(1):119-26. PubMed ID: 17012144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome-dependent degradation of guanosine 5'-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus.
    Xu J; Wu Y; Song P; Zhang M; Wang S; Zou MH
    Circulation; 2007 Aug; 116(8):944-53. PubMed ID: 17679617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydrofolate reductase protects endothelial nitric oxide synthase from uncoupling in tetrahydrobiopterin deficiency.
    Crabtree MJ; Hale AB; Channon KM
    Free Radic Biol Med; 2011 Jun; 50(11):1639-46. PubMed ID: 21402147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GTP cyclohydrolase I expression, protein, and activity determine intracellular tetrahydrobiopterin levels, independent of GTP cyclohydrolase feedback regulatory protein expression.
    Tatham AL; Crabtree MJ; Warrick N; Cai S; Alp NJ; Channon KM
    J Biol Chem; 2009 May; 284(20):13660-13668. PubMed ID: 19286659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein A-I mimetic peptide inhibits atherosclerosis by increasing tetrahydrobiopterin via regulation of GTP-cyclohydrolase 1 and reducing uncoupled endothelial nitric oxide synthase activity.
    Ning DS; Ma J; Peng YM; Li Y; Chen YT; Li SX; Liu Z; Li YQ; Zhang YX; Jian YP; Ou ZJ; Ou JS
    Atherosclerosis; 2021 Jul; 328():83-91. PubMed ID: 34118596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo.
    Schäfer A; Alp NJ; Cai S; Lygate CA; Neubauer S; Eigenthaler M; Bauersachs J; Channon KM
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1720-6. PubMed ID: 15242858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cerebral microvasculature in transgenic mice with endothelium targeted over-expression of GTP-cyclohydrolase I.
    Santhanam AV; d'Uscio LV; Katusic ZS
    Brain Res; 2015 Nov; 1625():198-205. PubMed ID: 26343845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GTP cyclohydrolase I gene transfer augments intracellular tetrahydrobiopterin in human endothelial cells: effects on nitric oxide synthase activity, protein levels and dimerisation.
    Cai S; Alp NJ; McDonald D; Smith I; Kay J; Canevari L; Heales S; Channon KM
    Cardiovasc Res; 2002 Sep; 55(4):838-49. PubMed ID: 12176133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.